Journal of The Egyptian Society of Nephrology and Transplantation

ORIGINAL ARTICLE
Year
: 2017  |  Volume : 17  |  Issue : 4  |  Page : 115--118

Association of serum fibroblast growth factor-23 with conventional cardiovascular risk factors in hemodialysis patients


Walaa H Mohammad1, Ahmad Bahie Elden Ahmad2, Noha G Sayed3 
1 Department of Internal Medicine and Nephrology, Nephrology Unit, Assiut University Hospital, Assiut, Egypt
2 Department of Internal Medicine and Cardiology, Cardiology and Critical Care Unit, Assiut University Hospital, Assiut, Egypt
3 Department of Clinical Pathology, South Oncology Institute, Assiut, Egypt

Correspondence Address:
Dr. Walaa H Mohammad
MD in Internal Medicine, Department of Internal Medicine and Nephrology, Nephrology Unit, Assiut University Hospital, Assiut, 71515
Egypt

Objectives We aimed to study the association of fibroblast growth factor-23 (FGF-23) with conventional cardiovascular risk factors in hemodialysis (HD) patients. Patients and methods This is a cross-sectional study, which was carried out on 90 HD patients. Demographic data were recorded in predefined data sheets. The blood samples for FGF-23 and other laboratory variables were collected and measured using the standard methods. The results and their relationships with FGF-23 were analyzed. Results In our study, there were insignificant correlations between FGF-23 and all clinical cardiovascular variables apart from a significant positive correlation between FGF-23 and systolic blood pressure (r=−0.546, P=0.004). Multivariate analysis failed to show any significant association between FGF-23 and systolic blood pressure (B=0.749, T=1.659, P=0.067). Conclusion Multiple linear regression analysis failed to show any significant association between FGF-23 and other conventional cardiovascular risk factors. We recommend using FGF-23 as an independent risk factor of cardiovascular morbidity and mortality, and searching for agents that control its level in HD patients.


How to cite this article:
Mohammad WH, Elden Ahmad AB, Sayed NG. Association of serum fibroblast growth factor-23 with conventional cardiovascular risk factors in hemodialysis patients.J Egypt Soc Nephrol Transplant 2017;17:115-118


How to cite this URL:
Mohammad WH, Elden Ahmad AB, Sayed NG. Association of serum fibroblast growth factor-23 with conventional cardiovascular risk factors in hemodialysis patients. J Egypt Soc Nephrol Transplant [serial online] 2017 [cited 2018 Aug 20 ];17:115-118
Available from: http://www.jesnt.eg.net/article.asp?issn=1110-9165;year=2017;volume=17;issue=4;spage=115;epage=118;aulast=Mohammad;type=0